Monday, November 4, 2024
HomeTagsAdam Graybill

Adam Graybill

Journey Biosciences Launches NaviDKD for People With Diabetes to Predict Long-Term Kidney Complications

Journey Biosciences, Inc., a biotechnology company offering biomarker-based predictive risk screening technologies for diabetes-related complications, announced the launch of its flagship product NaviDKD. NaviDKD, a...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics